| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
1 Medical Research Council Cancer Cell Unit, MRC/Hutchison Research Centre, and2 Department of Pathology, University of Cambridge, Cambridge, United Kingdom;3 Department of Experimental Pathology, Mayo Clinic, Rochester, Minnesota; and4 Molecular Oncology Unit, Cancer Research UK, Hammersmith Site, London, United Kingdom
Whereas two key steps in cervical carcinogenesis are integration of high-risk human papillomavirus (HR-HPV) and acquisition of an unstable host genome, the temporal association between these events is poorly understood. Chromosomal instability is induced when HR-HPV E7 oncoprotein is overexpressed from heterologous promoters in vitro. However, it is not known whether such events occur at the "physiologically" elevated levels of E7 produced by deregulation of the homologous HR-HPV promoter after integration. Indeed, an alternative possibility is that integration in vivo is favored in an already unstable host genome. We have addressed these issues using the unique human papillomavirus (HPV) 16-containing cervical keratinocyte cell line W12, which was derived from a low-grade squamous intraepithelial lesion and thus acquired HPV16 by "natural" infection. Whereas W12 at low passage contains HPV16 episomes only, long-term culture results in the emergence of cells containing integrated HPV16 only. We show that integration of HPV16 in W12 is associated with 3' deletion of the E2 transcriptional repressor, resulting in deregulation of the homologous promoter of the integrant and an increase in E7 protein levels. We further demonstrate that high-level chromosomal instability develops in W12 only after integration and that the forms of instability observed correlate with the physical state of HPV16 DNA and the level of E7 protein. Whereas intermediate E7 levels are associated with numerical chromosomal abnormalities, maximal levels are associated with both numerical and structural aberrations. HR-HPV integration is likely to be a critical event in cervical carcinogenesis, preceding the development of chromosomal abnormalities that drive malignant progression.
This article has been cited by other articles:
![]() |
S. I. Collins, C. Constandinou-Williams, K. Wen, L. S. Young, S. Roberts, P. G. Murray, and C. B.J. Woodman Disruption of the E2 Gene Is a Common and Early Event in the Natural History of Cervical Human Papillomavirus Infection: A Longitudinal Cohort Study Cancer Res., May 1, 2009; 69(9): 3828 - 3832. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jiang, J. G. Baseman, L. A. Koutsky, Q. Feng, C. Mao, N. B. Kiviat, and L. F. Xi Sequence Variation of Human Papillomavirus Type 16 and Measurement of Viral Integration by Quantitative PCR J. Clin. Microbiol., March 1, 2009; 47(3): 521 - 526. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Dall, C. G. Scarpini, I. Roberts, D. M. Winder, M. A. Stanley, B. Muralidhar, M. T. Herdman, M. R. Pett, and N. Coleman Characterization of Naturally Occurring HPV16 Integration Sites Isolated from Cervical Keratinocytes under Noncompetitive Conditions Cancer Res., October 15, 2008; 68(20): 8249 - 8259. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Kraus, C. Driesch, S. Vinokurova, E. Hovig, A. Schneider, M. von Knebel Doeberitz, and M. Durst The Majority of Viral-Cellular Fusion Transcripts in Cervical Carcinomas Cotranscribe Cellular Sequences of Known or Predicted Genes Cancer Res., April 1, 2008; 68(7): 2514 - 2522. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Vinokurova, N. Wentzensen, I. Kraus, R. Klaes, C. Driesch, P. Melsheimer, F. Kisseljov, M. Durst, A. Schneider, and M. von Knebel Doeberitz Type-Dependent Integration Frequency of Human Papillomavirus Genomes in Cervical Lesions Cancer Res., January 1, 2008; 68(1): 307 - 313. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Guo, Y. Gong, M. Deavers, E. G. Silva, Y. J. Jan, D. E. Cogdell, R. Luthra, E. Lin, H. C. Lai, W. Zhang, et al. Evaluation of a Commercialized In Situ Hybridization Assay for Detecting Human Papillomavirus DNA in Tissue Specimens from Patients with Cervical Intraepithelial Neoplasia and Cervical Carcinoma J. Clin. Microbiol., January 1, 2008; 46(1): 274 - 280. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-W. Cheng, M.-F. Wu, J. Wang, K.-T. Yeh, Y.-G. Goan, H.-L. Chiou, C.-Y. Chen, and H. Lee Human Papillomavirus 16/18 E6 Oncoprotein Is Expressed in Lung Cancer and Related with p53 Inactivation Cancer Res., November 15, 2007; 67(22): 10686 - 10693. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Topffer, A. Muller-Schiffmann, K. Matentzoglu, M. Scheffner, and G. Steger Protein tyrosine phosphatase H1 is a target of the E6 oncoprotein of high-risk genital human papillomaviruses J. Gen. Virol., November 1, 2007; 88(11): 2956 - 2965. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Capper, B. Britt-Compton, M. Tankimanova, J. Rowson, B. Letsolo, S. Man, M. Haughton, and D. M. Baird The nature of telomere fusion and a definition of the critical telomere length in human cells Genes & Dev., October 1, 2007; 21(19): 2495 - 2508. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Liu, S. A. Heilman, D. Illanes, G. Sluder, and J. J. Chen p53-Independent Abrogation of a Postmitotic Checkpoint Contributes to Human Papillomavirus E6-Induced Polyploidy Cancer Res., March 15, 2007; 67(6): 2603 - 2610. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.C.R. Ragin, F. Modugno, and S.M. Gollin The Epidemiology and Risk Factors of Head and Neck Cancer: a Focus on Human Papillomavirus Journal of Dental Research, February 1, 2007; 86(2): 104 - 114. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.T. Herdman, M. R. Pett, I. Roberts, W. O.F. Alazawi, A. E. Teschendorff, X.-Y. Zhang, M. A. Stanley, and N. Coleman Interferon-{beta} treatment of cervical keratinocytes naturally infected with human papillomavirus 16 episomes promotes rapid reduction in episome numbers and emergence of latent integrants Carcinogenesis, November 1, 2006; 27(11): 2341 - 2353. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. D. Dao, A. Duffy, B. A. Van Tine, S.-Y. Wu, C.-M. Chiang, T. R. Broker, and L. T. Chow Dynamic Localization of the Human Papillomavirus Type 11 Origin Binding Protein E2 through Mitosis While in Association with the Spindle Apparatus. J. Virol., May 1, 2006; 80(10): 4792 - 4800. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Pett, M. T. Herdman, R. D. Palmer, G. S. H. Yeo, M. K. Shivji, M. A. Stanley, and N. Coleman Selection of cervical keratinocytes containing integrated HPV16 associates with episome loss and an endogenous antiviral response PNAS, March 7, 2006; 103(10): 3822 - 3827. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Olaharski, R. Sotelo, G. Solorza-Luna, M. E. Gonsebatt, P. Guzman, A. Mohar, and D. A. Eastmond Tetraploidy and chromosomal instability are early events during cervical carcinogenesis Carcinogenesis, February 1, 2006; 27(2): 337 - 343. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Herrick, C. Conti, S. Teissier, F. Thierry, J. Couturier, X. Sastre-Garau, M. Favre, G. Orth, and A. Bensimon Genomic Organization of Amplified MYC Genes Suggests Distinct Mechanisms of Amplification in Tumorigenesis Cancer Res., February 15, 2005; 65(4): 1174 - 1179. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Scheckenbach, O. Lieven, K. Gotte, U. Bockmuhl, R. Zotz, H. Bier, and V. Balz p53 Codon 72 Polymorphic Variants, Loss of Allele-Specific Transcription, and Human Papilloma Virus 16 and/or 18 E6 Messenger RNA Expression in Squamous Cell Carcinomas of the Head and Neck Cancer Epidemiol. Biomarkers Prev., November 1, 2004; 13(11): 1805 - 1809. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Munger, A. Baldwin, K. M. Edwards, H. Hayakawa, C. L. Nguyen, M. Owens, M. Grace, and K. Huh Mechanisms of Human Papillomavirus-Induced Oncogenesis J. Virol., November 1, 2004; 78(21): 11451 - 11460. [Full Text] [PDF] |
||||
![]() |
K. Veeraraghavalu, M. Pett, R. V. Kumar, P. Nair, A. Rangarajan, M. A. Stanley, and S. Krishna Papillomavirus-Mediated Neoplastic Progression Is Associated with Reciprocal Changes in Jagged1 and Manic Fringe Expression Linked to Notch Activation J. Virol., August 15, 2004; 78(16): 8687 - 8700. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |